HIV and Inflamm-Aging: How Do We Reach the Summit of Healthy Aging? [0.03%]
HIV和炎症性衰老：我们如何才能实现健康老龄化？
Kerry Sheets,Jason V Baker
Kerry Sheets
People with HIV (PWH) are living longer and experiencing a greater burden of morbidity from non-AIDS-defining conditions. Chronically treated HIV disease is associated with ongoing systemic inflammation that contributes to the development o...
Weighing In: Glucagon-Like Peptide-1 Receptor Agonism for Persons With HIV [0.03%]
GLP-1受体激动剂用于HIV感染者
Teressa S Thomas,Suman Srinivasa
Teressa S Thomas
Weight gain among persons with HIV PWH) on contemporary antiretroviral therapy (ART) can extend beyond an initial return-to-health phenomenon and lead to overweight/obesity in the first 1 to 2 years, resulting in enhanced cardiometabolic ri...
Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication [0.03%]
艾滋病患者中兴奋剂的使用管理：从行为到药物的危害减少策略
Cheríe S Blair,Steven J Shoptaw
Cheríe S Blair
Stimulant use disorder poses substantial challenges to the health and well-being of people with HIV, contributing to increased HIV transmission risk and poor clinical outcomes. This article highlights the cultural significance of stimulant ...
CROI 2024: The Challenges of Sustained Viral Suppression, Advanced HIV Disease, and Ending the HIV Epidemic Targets [0.03%]
2024 CROI会议：持续病毒抑制、晚期艾滋病和终结艾滋病流行目标的挑战
Shauna H Gunaratne,Barbara S Taylor,Jason Zucker et al.
Shauna H Gunaratne et al.
Data on the HIV care cascade demonstrated challenges in achieving Ending the HIV Epidemic (EHE) targets across all 18 EHE focus metropolitan areas, but innovative adherence interventions using point-of-care tenofovir testing and motivationa...
Annukka A R Antar,Michael J Peluso
Annukka A R Antar
Studies of acute and post-acute COVID-19, including their biology, prevention, and treatment, were presented at the 2024 Conference on Retroviruses and Opportunistic Infections. Numerous studies reported on the impact of hybrid immunity (ie...
Michael J Corley,Scott L Letendre,Sam Nightingale
Michael J Corley
The 2024 Conference on Retroviruses and Opportunistic Infections featured new and impactful findings about neuropsychiatric complications in people with HIV and other infections. Reports included new evidence from low- and middleincome coun...
Sudipa Sarkar,Todd T Brown
Sudipa Sarkar
Comorbid conditions have a major impact on the health, quality of life, and survival of people with HIV (PWH), particularly as they age. The 2024 Conference on Retroviruses and Opportunistic Infections (CROI) featured many excellent reports...
CROI 2024: Tuberculosis, Mpox, and Other Infectious Complications in People With HIV [0.03%]
2024年CROI会议：HIV患者中的结核病、猴痘和其他感染并发症
Andrew D Kerkhoff,Jason Zucker,Diane V Havlir
Andrew D Kerkhoff
Several novel antituberculosis agents, including long-acting injectable agents in mouse models, have shown promise in preclinical and early clinical studies. This encouraging news is offset by the failures of a tuberculosis (TB) vaccine to ...
Mario Stevenson
Mario Stevenson
Scientists from around the world gathered in Denver for the Conference on Retroviruses and Opportunistic Infections (CROI). The conference maintained its existing format and used a combination of plenary lectures, workshops, oral abstract s...
CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases [0.03%]
2024年逆转录病毒和机会性感染大会(CROI)：艾滋病和其他性传播疾病的全球流行病学和预防
Albert Y Liu,Susan P Buchbinder
Albert Y Liu
At the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), investigators presented updates on the global HIV epidemic, focusing on ongoing disparities by race/ethnicity in the US, the ongoing concentration of new infections...